04.02.2013 Views

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21) Application No.: 00819/KOLNP/2005 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 05/05/2005 (43) Publication Date: 09/06/2006<br />

(54) Title <strong>of</strong> <strong>the</strong> invention: SOLID PREPARATION<br />

(51) International classification : A61K<br />

45/06,9/20,9/30,31/<br />

155,31/427,A61P<br />

3/10<br />

(31) Priority Document No : 2002-294045<br />

(32) Priority Date : 07/10/2002<br />

(33) Name <strong>of</strong> priority country : JP<br />

(86) International Application No and : PCT/JP03/012781<br />

Filing Date<br />

: 06/10/2003<br />

(87) International Publication No : WO 04/030700 A1<br />

(61) Patent <strong>of</strong> addition to Application No : NIL<br />

Filed on : N.A.<br />

(62) Divisional to Application No : NIL<br />

Filed on : N.A.<br />

(57) Abstract:<br />

(71) Name <strong>of</strong> Applicant:<br />

TAKEDA PHARMACEUTICAL COMPANY<br />

Address <strong>of</strong> <strong>the</strong> Applicant:<br />

1-1 DOSHOMACHI 4-CHOME CHUO-KU,<br />

OSAKA-SHI OSAKA 541-0045 JAPAN<br />

(72) Name <strong>of</strong> <strong>the</strong> Inventor:<br />

1. KOIKE MASAHIKO<br />

2. KOYAMA HIROYOSHI<br />

3. HAMAGUCHI NAORU<br />

Filed U/S 5(2) before The <strong>Patents</strong> (Amendment)<br />

Act, 2005: NO<br />

The present invention provides a solid preparation containing an insulin sensitizer and an active ingredient (except insulin sensitizers),<br />

which is useful as a <strong>the</strong>rapeutic drug for diabetes and <strong>the</strong> like, and which is superior in preparation characteristics such as content<br />

uniformity and dissolution property <strong>of</strong> <strong>the</strong> insulin sensitizer and <strong>the</strong> active ingredient (except insulin sensitizers), preparation hardness<br />

and <strong>the</strong> like<br />

(FIG. - Nil)<br />

The Patent Office Journal 09/06/2006 11024

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!